Documents Uncovered by Judicial Watch Detail Big Pharma Campaign Access to Democratic Governors During 2012 National Governors Association Meeting
March 28, 2012 14:11 ET
|
Judicial Watch
WASHINGTON, DC--(Marketwire - Mar 28, 2012) - Judicial Watch, the public interest group that investigates and prosecutes government corruption, announced today that it has uncovered documents...
Human Genome Sciences and GlaxoSmithKline Announce Positive Results in Second of Two Phase 3 Trials of BENLYSTA(TM) in Systemic Lupus Erythematosus
November 02, 2009 00:01 ET
|
Human Genome Sciences
ROCKVILLE, MD and LONDON--(Marketwire - November 2, 2009) - Human Genome Sciences, Inc.
(NASDAQ: HGSI) and GlaxoSmithKline PLC (GSK) today announced that BENLYSTA™ (belimumab)
met the primary...
Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus
July 20, 2009 00:01 ET
|
Human Genome Sciences, Inc.
ROCKVILLE, MD and LONDON--(Marketwire - July 20, 2009) - Human Genome Sciences, Inc.
(NASDAQ: HGSI) and GlaxoSmithKline PLC (GSK) today announced that BENLYSTA™ (belimumab,
formerly...
Cleveland Attorney of Anderson Law Offices Says Avandia Study Based On "Junk Science"
June 05, 2009 12:42 ET
|
Anderson Law Offices, LLC
CLEVELAND, June 5, 2009 (GLOBE NEWSWIRE) -- Mass tort trial lawyer Ben Anderson of Anderson Law Offices says "junk science" is the basis for a new study sponsored by London-based GlaxoSmithKline...